FindTrial
Sign In

Administration of fibrinogen concentrate combined with prothrombin complex maintains hemostasis in children undergoing Liver Transplantation

Administration of fibrinogen concentrate combined with prothrombin complex maintains hemostasis in children undergoing Liver Transplantation

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500097182
Enrollment
Unknown
Registered
2025-02-13
Start date
2024-06-02
Completion date
Unknown
Last updated
2025-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coagulopathy in pediatric liver transplantation

Interventions

control group:FC and PCC were not used intraoperatively.
Study Groups:Fibrinogen concentrate (FC) and prothrombin complex (PCC) are used intraoperatively.

Sponsors

The First Affiliated Hospital, Zhejiang University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 12 Years

Inclusion criteria

Inclusion criteria: All children who underwent liver transplantation in our hospital from March 2019 to March 2024. Age 0-12 years.

Exclusion criteria

Exclusion criteria: Patients with missing data. Transplanters again. Joint organ transplant recipients. Combined with other congenital diseases (congenital coagulation dysfunction, heart disease, etc.).

Design outcomes

Primary

MeasureTime frame
Coagulation function;—

Countries

China

Contacts

Public Contactwangmi

The First Affiliated Hospital, Zhejiang University School of Medicine

1521061@zju.edu.cn+86 187 6718 9295

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026